Delivery of nanoparticles to brain metastases of breast cancer using a cellular Trojan horse

Cancer Nanotechnology

Volumn 3, Issue 1-6, 2012, Pages 47-54

  Choi, Mi Ran ^a   Bardhan, Rizia ^b   Stanton Maxey, Katie J ^a   Badve, Sunil ^a   Nakshatri, Harikrishna ^a   Stantz, Keith M ^a,c   Cao, Ning ^c   Halas, Naomi J ^b   Clare, Susan E ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RICE UNIVERSITY   (United States)

^c PURDUE UNIVERSITY   (United States)

Author keywords

Blood brain barrier; Brain metastasis; Breast cancer; Gold silica nanoshell; Nanoparticle

Indexed keywords

GOLD NANOPARTICLE; MICROSPHERE; NANOSHELL; NANOSPHERE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN METASTASIS; BREAST CANCER; CELL LABELING; CELL TRANSPLANTATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FEMALE; FLUORESCENCE IMAGING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VIVO STUDY; MACROPHAGE; MACROPHAGE ACTIVATION; MOLECULAR DIAGNOSIS; MOLECULARLY TARGETED THERAPY; MONOCYTE; MOUSE; NANOBIOTECHNOLOGY; NANOFABRICATION; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; SYSTEMIC CIRCULATION; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84870326595     PISSN: 18686958     EISSN: 18686966     Source Type: Journal    
DOI: 10.1007/s12645-012-0029-9     Document Type: Article

References (46)

1. Afergan E, Epstein H, Dahan R, Koroukhov N, Rohekar K, Danenberg HD, Golomb G (2008) Delivery of serotonin to the brain by monocytes following phagocytosis of liposomes. J Contr Release 132(2): 84-90.
2. Bardhan R, Grady NK, Halas NJ (2008) Nanoscale control of near-infrared fluorescence enhancement using Au nanoshells. Small 4: 1716-1722. doi: 10. 1002/smll. 200800405.
3. Bardhan R, Chen WX, Perez-Torres C, Bartels M, Huschka RM, Zhao LL, Morosan E, Pautler RG, Joshi A, Halas NJ (2009a) Nanoshells with targeted simultaneous enhancement of magnetic and optical imaging and photothermal therapeutic response. Adv Funct Mater 19(24): 3901-3909. doi: 10. 1002/adfm. 200901235.
4. Bardhan R, Grady NK, Cole JR, Joshi A, Halas NJ (2009b) Fluorescence Enhancement by Au Nanostructures: Nanoshells and Nanorods. ACS Nano. doi: 10. 1021/nn900001q.
5. Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE (2004) Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 22(14): 2865-2872. doi: 10. 1200/JCO. 2004. 12. 14922/14/2865.
6. Begley DJ (2004) ABC transporters and the blood-brain barrier. Curr Pharm Des 10(12): 1295-1312.
7. Bendell JC, Domchek SM, Burstein HJ, Harris L, Younger J, Kuter I, Bunnell C, Rue M, Gelman R, Winer E (2003) Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma. Cancer 97(12): 2972-2977. doi: 10. 1002/cncr. 11436.
8. Brinson BE, Lassiter JB, Levin CS, Bardhan R, Mirin N, Halas NJ (2008) Nanoshells made easy: improving Au layer growth on nanoparticle surfaces. Langmuir 24(24): 14166-14171. doi: 10. 1021/la802049p.
9. Burstein HJ, Lieberman G, Slamon DJ, Winer EP, Klein P (2005) Isolated central nervous system metastases in patients with HER2-overexpressing advanced breast cancer treated with first-line trastuzumab-based therapy. Ann Oncol 16(11): 1772-1777.
10. Cairncross JG, Posner JB (1983) The management of brain metastases. Oncology of the nervous system. Nijhoff, Boston.
11. Carman AJ, Mills JH, Krenz A, Kim D-G, Bynoe MS (2011) Adenosine receptor signaling modulates permeability of the blood-brain barrier. J Neurosci 31: 13272-13280.
12. Choi MR, Stanton-Maxey KJ, Stanley JK, Levin CS, Bardhan R, Akin D, Badve S, Sturgis J, Robinson JP, Bashir R, Halas NJ, Clare SE (2007) A cellular Trojan Horse for delivery of therapeutic nanoparticles into tumors. Nano Lett 7(12): 3759-3765. doi: 10. 1021/nl072209h.
13. Clayton AJ, Danson S, Jolly S, Ryder WD, Burt PA, Stewart AL, Wilkinson PM, Welch RS, Magee B, Wilson G, Howell A, Wardley AM (2004) Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer. Br J Cancer 91(4): 639-643. doi: 10. 1038/sj. bjc. 66019706601970.
14. Dou H, Grotepas CB, McMillan JM, Destache CJ, Chaubal M, Werling J, Kipp J, Rabinow B, Gendelman HE (2009) Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS. J Immunol 183(1): 661-669.
15. Duff DG, Baiker PP, Edwards A (1993) A new hydrosol of gold clusters. 1. Formation and particle size variation. Langmuir 9: 2301-2309.
16. Freeman BJ, Roberts MS, Vogler CA, Nicholes A, Hofling AA, Sands MS (1999) Behavior and therapeutic efficacy of beta-glucuronidase-positive mononuclear phagocytes in a murine model of mucopolysaccharidosis type VII. Blood 94(6): 2142-2150.
17. Graff CL, Pollack GM (2004) Drug transport at the blood-brain barrier and the choroid plexus. Curr Drug Metabol 5(1): 95-108.
18. Grossi F, Scolaro T, Tixi L, Loprevite M, Ardizzoni A (2001) The role of systemic chemotherapy in the treatment of brain metastases from small-cell lung cancer. Crit Rev Oncol Hematol 37(1): 61-67.
19. Hochstenbag MM, Twijnstra A, Wilmink JT, Wouters EF, ten Velde GP (2000) Asymptomatic brain metastases (BM) in small cell lung cancer (SCLC): MR-imaging is useful at initial diagnosis. J Neurooncol 48(3): 243-248.
20. Kennedy DW, Abkowitz JL (1998) Mature monocytic cells enter tissues and engraft. Proc Natl Acad Sci U S A 95(25): 14944-14949.
21. Klos KJ, O'Neill BP (2004) Brain metastases. Neurologist 10(1): 31-46. doi: 10. 1097/01. nrl. 0000106922. 83090. 7101. nrl. 0000106922. 83090. 71.
22. Lin NU, Winer EP (2007) Brain metastases: the HER2 paradigm. Clin Cancer Res 13(6): 1648-1655.
23. Lin NU, Claus E, Sohl J, Razzak AR, Arnaout A, Winer EP (2008) Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases. Cancer 113(10): 2638-2645. doi: 10. 1002/cncr. 23930.
24. Lo SS, Chang EL, Suh JH (2005) Stereotactic radiosurgery with and without whole-brain radiotherapy for newly diagnosed brain metastases. Expert Rev Neurother 5(4): 487-495. doi: 10. 1586/14737175. 5. 4. 487.
25. Lockman PR, Mittapalli RK, Taskar KS, Rudraraju V, Gril B, Bohn KA, Adkins CE, Roberts A, Thorsheim HR, Gaasch JA, Huang S, Palmieri D, Steeg PS, Smith QR (2010) Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer. Clin Cancer Res 16(23): 5664-5678. doi: 1078-0432. CCR-10-1564.
26. Mahmoud-Ahmed ASS, Lee SY et al (2002) Results of whole brain radiotherapy in patients with brain metastases from breast cancer: a retrospective study. Int J Radiat Oncol Biol Phys 54: 810-817.
27. Morantz RA, Wood GW, Foster M, Clark M, Gollahon K (1979) Macrophages in experimental and human brain tumors. Part 2: studies of the macrophage content of human brain tumors. J Neurosurg 50(3): 305-311. doi: 10. 3171/jns. 1979. 50. 3. 0305.
28. Muldoon LL, Soussain C, Jahnke K, Johanson C, Siegal T, Smith QR, Hall WA, Hynynen K, Senter PD, Peereboom DM, Neuwelt EA (2007) Chemotherapy delivery issues in central nervous system malignancy: a reality check. J Clin Oncol 25(16): 2295-2305.
29. Oldenburg SJ, Averitt RD, Westcott SL, Halas NJ (1998) Nanoengineering of optical resonances. Chem Phys Lett 288: 243-247.
30. Palmieri D, Bronder JL, Herring JM, Yoneda T, Weil RJ, Stark AM, Kurek R, Vega-Valle E, Feigenbaum L, Halverson D, Vortmeyer AO, Steinberg SM, Aldape K, Steeg PS (2007) Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain. Cancer Res 67(9): 4190-4198.
31. Pardridge WM (2005) The blood-brain barrier: bottleneck in brain drug development. NeuroRx 2(1): 3-14.
32. Patchell RA, Regine WF (2003) The rationale for adjuvant whole brain radiation therapy with radiosurgery in the treatment of single brain metastases. Tech Canc Res Treat 2(2): 111-115.
33. Posner JB (1992) Management of brain metastases. Rev Neurol (Paris) 148(6-7): 477-487.
34. Posner JB (1995) Neurologic complications of cancer. Davis, Philadelphia.
35. Schackert G, Simmons RD, Buzbee TM, Hume DA, Fidler IJ (1988) Macrophage infiltration into experimental brain metastases: occurrence through an intact blood-brain barrier. J Natl Canc Inst 80(13): 1027-1034.
36. Seute T, Leffers P, ten Velde GP, Twijnstra A (2004) Neurologic disorders in 432 consecutive patients with small cell lung carcinoma. Cancer 100(4): 801-806. doi: 10. 1002/cncr. 20043.
37. Sneed PK, Lamborn KR, Forstner JM, McDermott MW, Chang S, Park E, Gutin PH, Phillips TL, Wara WM, Larson DA (1999) Radiosurgery for brain metastases: is whole brain radiotherapy necessary? Int J Radiat Oncol Biol Phys 43(3): 549-558.
38. Stemmler HJ, Kahlert S, Siekiera W, Untch M, Heinrich B, Heinemann V (2006) Characteristics of patients with brain metastases receiving trastuzumab for HER2 overexpressing metastatic breast cancer. Breast 15(2): 219-225.
39. Stoeber W, Fink A, Bihb EJ (1968) Controlled growth of monodisperse silica spheres in the micron size range. J Colloid Interface Sci 26: 62-69.
40. Strik HM, Stoll M, Meyermann R (2004) Immune cell infiltration of intrinsic and metastatic intracranial tumours. Anticancer Res 24(1): 37-42.
41. Stuschke M, Eberhardt W, Pottgen C, Stamatis G, Wilke H, Stuben G et al (1999) Prophylactic cranial irradiation in locally advanced non-small cell lung cancer after multimodality treatment: long-term follow-up and investigations of late neuropsychologic effects. J Clin Oncol 17: 2700-2709.
42. Tam F, Goodrich GP, Johnson BR, Halas NJ (2007) Plasmonic enhancement of molecular fluorescence. Nano Lett 7: 496-501. doi: 10. 1021/nl062901x.
43. Walker AE, Robins M, Weinfeld FD (1985) Epidemiology of brain tumors: the national survey of intracranial neoplasms. Neurology 35(2): 219-226.
44. Weil RJ, Palmieri DC, Bronder JL, Stark AM, Steeg PS (2005) Breast cancer metastasis to the central nervous system. Am J Pathol 167(4): 913-920.
45. Yau T, Swanton C, Chua S, Sue A, Walsh G, Rostom A, Johnston SR, O'Brien ME, Smith IE (2006) Incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumab. Acta Oncol 45(2): 196-201.
46. Yoneda T, Williams PJ, Hiraga T, Niewolna M, Nishimura R (2001) A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro. J Bone Miner Res 16(8): 1486-1495.